Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Turkish Speech Analysis Development Study for Major Neurocognitive Disorder Due to Alzheimer's Disease

NCT05732519 is registered in ClinicalTrials.gov with mihrimah ozturk as lead sponsor.

NCT NCT05732519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05732519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Turkish Speech Analysis Development Study for Major Neurocognitive Disorder Due to Alzheimer's Disease
Lead sponsor
mihrimah ozturk
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2023
Completion date
December 16, 2025
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment